PR Newswire
London, May 29
For immediate release
29 May 2015
THE BIOTECH GROWTH TRUST PLC
(the "Company")
MARKET PURCHASE OF COMPANY'S OWN SHARES
Notification is given, pursuant to the authority granted at the Annual General Meeting of the Company held on 10 July 2014 to make market purchases of the Company's own shares up to an aggregate maximum of 10,170,676 that a market total of 229,688 Ordinary shares of 25p each in the capital of the Company were purchased today by the Company at a price of 803.25p per share. These shares will be held in treasury.
Following this transaction and in conformity with the provisions of the Transparency Directive, the Company hereby notifies the market that the resultant number of Ordinary shares held by the Company in treasury is 6,199,875 and the total number of Ordinary shares that the Company has in issue is 68,886,347 so that the total number of voting rights in the Company following the repurchase is 62,686,472.
The figure of 62,686,472 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.
For and on behalf of
Frostrow Capital LLP
Company Secretary
For further information, please contact:
Mark Pope
Frostrow Capital LLP
Tel: 020 3 008 4913
